- /
- Supported exchanges
- / US
- / AMBBY.PINK
Ambu A/S (AMBBY PINK) stock market data APIs
Ambu A/S Financial Data Overview
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Ambu A/S data using free add-ons & libraries
Get Ambu A/S Fundamental Data
Ambu A/S Fundamental data includes:
- Net Revenue: 6 037 M
- EBITDA: 928 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-22
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ambu A/S News
New
3 European Stocks Estimated To Be Undervalued By Up To 47.6%
As the European markets experience a modest upswing, with the pan-European STOXX Europe 600 Index rising by 1.77% following the reopening of the U.S. federal government, investor sentiment remains cau...
European Growth Companies With Up To 34% Insider Ownership
As European markets face a pullback amid concerns about overvaluation in artificial intelligence-related stocks, investors are increasingly cautious, with major indexes such as Germany's DAX and Franc...
Did Strong Results and New Guidance Just Shift Ambu's (CPSE:AMBU B) Investment Narrative?
Ambu A/S recently reported strong full-year results with sales of DKK 6,037 million and net income of DKK 609 million for the period ending September 30, 2025, and has announced an annual dividend of ...
Ambu (CPSE:AMBU B) Valuation: How Improved Results and Guidance Shape Investor Sentiment
Ambu (CPSE:AMBU B) just delivered full-year results showing sharp improvements in both sales and profit, along with upbeat financial guidance for 2025/26. Investors will be watching these developments...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.